BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 11485043)

  • 1. Effects of a novel, selective, sigma1-ligand, MS-377, on phencyclidine-induced behaviour.
    Takahashi S; Takagi K; Horikomi K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):81-6. PubMed ID: 11485043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
    Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
    Gao J; Qin R; Li M
    J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D
    Riga MS; Paz V; Didriksen M; Celada P; Artigas F
    Eur J Pharmacol; 2023 Aug; 953():175802. PubMed ID: 37295763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine.
    Matsuura A; Fujita Y; Iyo M; Hashimoto K
    Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands.
    Lladó-Pelfort L; Troyano-Rodriguez E; van den Munkhof HE; Cervera-Ferri A; Jurado N; Núñez-Calvet M; Artigas F; Celada P
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):614-25. PubMed ID: 26781158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary bladder sigma-1 receptors: A new target for cystitis treatment.
    González-Cano R; Artacho-Cordón A; Romero L; Tejada MA; Nieto FR; Merlos M; Cañizares FJ; Cendán CM; Fernández-Segura E; Baeyens JM
    Pharmacol Res; 2020 May; 155():104724. PubMed ID: 32105755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of developmentally regulated PCP-responsive non-coding RNA, prt6, in the rat thalamus.
    Takebayashi H; Yamamoto N; Umino A; Nishikawa T
    PLoS One; 2014; 9(6):e97955. PubMed ID: 24886782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of high affinity Σ1 receptor selective compounds.
    Luedtke RR; Perez E; Yang SH; Liu R; Vangveravong S; Tu Z; Mach RH; Simpkins JW
    Brain Res; 2012 Mar; 1441():17-26. PubMed ID: 22285434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for σ
    Schmidt HR; Betz RM; Dror RO; Kruse AC
    Nat Struct Mol Biol; 2018 Oct; 25(10):981-987. PubMed ID: 30291362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
    Rahmadi M; Mori T; Kanazawa M; Kubota H; Shibasaki M; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Apr; 33(2):49-56. PubMed ID: 25069239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of P2X7 receptors in a rodent PCP-induced schizophrenia model.
    Koványi B; Csölle C; Calovi S; Hanuska A; Kató E; Köles L; Bhattacharya A; Haller J; Sperlágh B
    Sci Rep; 2016 Nov; 6():36680. PubMed ID: 27824163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats.
    Cifani C; Micioni Di Bonaventura E; Botticelli L; Del Bello F; Giorgioni G; Pavletić P; Piergentili A; Quaglia W; Bonifazi A; Schepmann D; Wünsch B; Vistoli G; Micioni Di Bonaventura MV
    ACS Chem Neurosci; 2020 Oct; 11(19):3107-3116. PubMed ID: 32886484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Modulation of the Sigma-1 Receptor Elicits Antipsychotic-like Effects.
    Chen J; Li G; Qin P; Chen J; Ye N; Waddington JL; Zhen X
    Schizophr Bull; 2022 Mar; 48(2):474-484. PubMed ID: 34865170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pridopidine Reverses Phencyclidine-Induced Memory Impairment.
    Sahlholm K; Valle-León M; Fernández-Dueñas V; Ciruela F
    Front Pharmacol; 2018; 9():338. PubMed ID: 29692729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Novel σ
    Morató X; Fernández-Dueñas V; Pérez-Villamor P; Valle-León M; Vela JM; Merlos M; Burgueño J; Ciruela F
    ACS Chem Neurosci; 2023 Jun; 14(11):2201-2207. PubMed ID: 37191585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands.
    Pascarella G; Antonelli L; Narzi D; Battista T; Fiorillo A; Colotti G; Guidoni L; Morea V; Ilari A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting sigma receptors: novel medication development for drug abuse and addiction.
    Matsumoto RR
    Expert Rev Clin Pharmacol; 2009 Jul; 2(4):351-8. PubMed ID: 22112179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.